FDA Adverse Event Malfunction Summary report: N

RADIFOCUS GLIDEWIRE ADVANTAGE

MDR report key: 10017303 · Received May 1, 2020

Report

Report Number
9681834-2020-00072
Event Type
Malfunction
Date Received
May 1, 2020
Date of Event
April 21, 2020
Report Date
May 1, 2020
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DQX
PMA / PMN Number
K063372
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS BEING SUBMITTED AS FOLLOW UP NO. 1 . THIS REPORTED EVENT HAS BEEN DEEMED NOT REPORTABLE BASED OFF THE INSPECTION OF THE ACTUAL SAMPLE. THE DEVICE INVOLVED IN THIS COMPLAINT HAS BEEN VERIFIED TO BE THE NORMAL PRODUCT; THEREFORE, IS NOT A REPORTABLE EVENT.

Additional Manufacturer Narrative · 1

UDI - NOT REQUIRED FOR PRODUCT CODE. IMPLANTED DATE: DEVICE WAS NOT IMPLANTED. EXPLANTED DATE: DEVICE WAS NOT EXPLANTED. PMA/510(K)- K122590, K163004. THE ACTUAL DEVICE HAS NOT BEEN RETURNED FOR EVALUATION. THE INVESTIGATION IS CURRENTLY ONGOING. A FOLLOW UP REPORT WILL BE SUBMITTED ONCE THE INVESTIGATION IS COMPLETE. A REVIEW OF THE DEVICE HISTORY RECORD AND PRODUCT RELEASE DECISION CONTROL SHEET OF THE PRODUCT CODE/LOT# COMBINATION WAS CONDUCTED WITH NO FINDINGS. (B)(4).

Description of Event or Problem · 1

THE USER FACILITY REPORTED THAT A BUMP WAS RECOGNIZED ON THE INVOLVED RADIFOCUS GLIDEWIRE ADVANTAGE DURING PREPARATION, IT WAS VISIBLE AND TACTILE. THERE WAS NO PATIENT INVOLVED, EVENT OCCURRED PRE-TREATMENT. THE GW WAS NOT USED. THE PROCEDURE OUTCOME AND PATIENT OUTCOME WAS NOT REPORTED. ADDITIONAL INFORMATION WAS RECEIVED ON 24APR2020. THE EVENT DID NOT SIGNIFICANTLY DELAY THE PROCEDURE. THE DEVICE WAS REPLACED BY ANOTHER GLIDEWIRE ADVANTAGE. FOLLOWING THE EVENT, THE PATIENT WAS TREATED AS INTENDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
482902 RADIFOCUS GLIDEWIRE ADVANTAGE WIRE, GUIDE, CATHETER DQX TERUMO CORPORATION, ASHITAKA NA 191105

Patients

Seq Age Sex Outcome Treatment
1